Cathal N. Young, O’Reilly & Co. Solicitors recently represented Emily Felix in a significant legal challenge concerning access to Skyclarys (omaveloxolone), a treatment for Friedreich’s ataxia, a rare and progressive neuromuscular condition. The case brought important questions about access to treatment for patients with rare diseases and the need for timely decision-making where a condition […]